Andrew MacGarvey & Conditor Capital launch Coronado Research to maximise the use of data and technology in drug development; Dr. Nicholas Edwards announced as Chair
Published on 08/07/2025 at 18:05 | prnewswire.co.uk
en | CA7609751028 | ANDREW | boerse | 67969489 |
